IP Library Granted Patent US 7,351,723
Granted Patent B2
US 7,351,723 · App. 10/855,703 · Granted Apr 1, 2008

Freeze-dried pantoprazole preparation and pantoprazole injection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,351,723
App. No.
10/855,703
Granted
Apr 1, 2008
Kind
B2
Abstract

Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have advantageous properties when reconstituted for injection.

Claims (23)

1. Lyophilized preparation consisting of:

(a) 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole (pantoprazole) or a solvate, hydrate, salt, hydrate of a salt or solvate of a salt thereof;

(b) ethylenediamine tetraacetic acid and/or a suitable salt thereof, and

(c) sodium hydroxide and/or sodium carbonate.

2. The preparation according to claim 1 , wherein the pantoprazole is pantoprazole sodium.

3. The preparation according to claim 1 , wherein the pantoprazole is pantoprazole sodium sesquihydrate.

4. The preparation according to claim 1 , wherein the pantoprazole is pantoprazole magnesium.

5. The preparation according to claim 1 , wherein the pantoprazole is pantoprazole magnesium dihydrate.

6. The preparation according to claim 1 , wherein the pantoprazole is (−)-pantoprazole or a solvate, hydrate, salt, hydrate of a salt or solvate of a salt thereof.

7. The preparation according to claim 1 , wherein the ethylenediamine tetraacetic acid is present as ethylenediamine tetraacetic acid disodium salt.

8. The preparation according to claim 2 , wherein the ethylenediamine tetraacetic acid is present as ethylenediamine tetraacetic acid disodium salt.

9. The preparation according to claim 3 , wherein the ethylenediamine tetraacetic acid is present as ethylenediamine tetraacetic acid disodium salt.

10. The preparation according to claim 4 , wherein the ethylenediamine tetraacetic acid is present as ethylenediamine tetraacetic acid disodium salt.

11. The preparation according to claim 5 , wherein the ethylenediamine tetraacetic acid is present as ethylenediamine tetraacetic acid disodium salt.

12. The preparation according to claim 6 , wherein the ethylenediamine tetraacetic acid is present as ethylenediamine tetraacetic acid disodium salt.

13. The preparation according to claim 1 , consisting of

(a) Pantoprazole sodium;

(b) ethylenediamine tetraacetic acid disodium salt; and

(c) sodium hydroxide.

14. The preparation according to claim 1 consisting of:

(a) Pantoprazole sodium sesquihydrate;

(b) ethylenediamine tetraacetic acid disodium salt; and

(c) sodium hydroxide.

Assignments (5)
CHANGE OF NAME Recorded Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
MERGER Recorded Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
MERGER Recorded Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
CHANGE OF NAME Recorded Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
CHANGE OF NAME Recorded Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →